Concepedia

Grant Langdon

GL

16

Publications

904

Citations

13

H-Index

2004

Active since

Affiliations

University of Cape Town(Current)

Pfizer (United Kingdom)

Uppsala University

Pfizer (United States)

Medicines for Malaria Venture

Grant Langdon is an author at University of Cape Town specializing in medicine, pharmacotherapy, and pharmacology.

Top concepts

Publications per year

2004–2021

16

Publications

16

The FcRn inhibitor rozanolixizumab reduces human serum IgG concentration: A randomized phase 1 study

Rocío Lledó‐García, Shikiko Watanabe, Grant Langdon et al. · Science Translational Medicine · 2017 · 195 citations

Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption

Justin Wilkins, Radojka M. Savić, Mats O. Karlsson et al. · Antimicrobial Agents and Chemotherapy · 2008 · 147 citations · Full text

Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients

Justin Wilkins, Grant Langdon, Helen McIlleron et al. · British Journal of Clinical Pharmacology · 2011 · 107 citations · Full text

Phase 2 multiple-dose study of an FcRn inhibitor, rozanolixizumab, in patients with primary immune thrombocytopenia

Tadeusz Robak, Maciej Kaźmierczak, Isidro Jarque et al. · Blood Advances · 2020 · 107 citations · Full text

, , +23

Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients

Justin Wilkins, Grant Langdon, Helen McIlleron et al. · European Journal of Clinical Pharmacology · 2006 · 78 citations

, , +8

Rows per page

1–5 of 16